2020 Emerging Cancer Diagnostic Technologies and Supplier Profiles

Report
110 Pages
April 2020
Region: Global
VPG Market Research
ID: 4871490

This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

Contains 110 pages

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2361EUR$2,450USD£2,031GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3373EUR$3,500USD£2,901GBP

Related Topics

Related Reports

2023-2027 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2024-2032

Global Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030

Next-Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F